Cheminformatics for Optimized Small-Molecule Libraries
2026-08-11
Moret et al. present a data-driven framework for comparing and designing small-molecule libraries using target coverage, binding selectivity, cellular phenotypes, chemical structure, clinical-development status, and user-defined preferences. The resulting LSP-OptimalKinase and LSP-MoA collections show how computational optimization can produce smaller, more informative libraries with reduced off-target overlap.
Boc-D-FMK in Mechanistic Apoptosis Assays
2026-08-10
Boc-D-FMK is a cell-permeable pan-caspase inhibitor for testing whether apoptosis contributes to inflammatory and fibrotic phenotypes. This article pairs its mechanistic strengths with assay-design insights from a hepatic stellate-cell study to improve causal interpretation and experimental controls.
In Vitro Drug Response Metrics in Cancer
2026-08-09
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that drug-induced growth inhibition and cell death are related but non-equivalent responses. The framework has practical value for designing time-resolved cancer assays and interpreting compounds whose cytostatic and cytotoxic effects emerge at different rates.
Targeted Amikacin Delivery into Mycobacterial Granulomas
2026-08-08
Montes-Worboys and colleagues investigated monocyte-derived dendritic cells as carriers for fluorescein-labeled amikacin in mice with disseminated Mycobacterium avium infection. The study showed that loaded dendritic cells reached granulomas without detectable inflammatory activation, supporting a site-directed strategy to concentrate therapy while potentially limiting systemic aminoglycoside exposure.
Self-Adaptive Nanocarriers in Pancreatic Cancer
2026-08-07
The ACS Nano study developed DATCPT, a pH/reactive oxygen species-responsive nanocarrier designed to overcome circulation, tumor uptake, extracellular matrix, and metastatic barriers in orthotopic pancreatic cancer. Its sequential charge exposure and ROS-triggered chemistry improved tumor penetration while coupling camptothecin delivery to matrix remodeling and suppression of ATP-dependent tumor-derived microvesicles.
LY364947: TGF-β Type I Receptor Kinase Inhibitor in EMT Rese
2026-08-07
LY364947 empowers researchers to dissect TGF-β signaling and reliably inhibit epithelial-mesenchymal transition (EMT) in both cellular and in vivo models. Its robust selectivity, proven workflow enhancements, and troubleshooting flexibility make it indispensable for preclinical studies spanning fibrosis, cancer biology, and neurovascular research.
IGF2BP1-Driven TUBB4B Stabilization Fuels Hepatic Stellate A
2026-08-06
This study identifies IGF2BP1 as a key m6A reader that stabilizes TUBB4B mRNA, promoting hepatic stellate cell activation and fibrogenesis. These findings highlight the IGF2BP1/TUBB4B/FAK axis as a potential therapeutic target for liver fibrosis and open new avenues for methylation-related liver disease research.
Tris(2-carboxyethyl) Phosphine Hydrochloride: Innovating Pro
2026-08-06
Discover how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) enables next-generation protein capture-and-release workflows. This article uniquely explores its role in signal amplification, assay sensitivity, and advanced redox protocols for protein analysis.
HDAC Inhibitors Suppress NUT Carcinoma by Targeting Chromati
2026-08-05
Shiota et al. identified diverse histone deacetylase (HDAC) inhibitors as potent repressors of NUT function in NUT carcinoma (NC), providing mechanistic insight into chromatin megadomain regulation. Their high-throughput screen reveals a novel therapeutic avenue for this aggressive cancer, emphasizing the translational potential of HDAC inhibition.
Acetylcholine Chloride: Neurotransmitter Roles & Research Ut
2026-08-05
Acetylcholine Chloride is a primary acetylcholine neurotransmitter analog essential for dissecting cholinergic signaling pathways. Its well-characterized solubility and stability make it a benchmark tool in neuromuscular and autonomic nervous system research. Recent studies link its mechanistic significance to gut-brain axis modulation in epilepsy models.
IGF2BP1-m6A-TUBB4B Axis Drives Hepatic Stellate Cell Activat
2026-08-04
The reference study elucidates how the m6A reader IGF2BP1 promotes hepatic stellate cell (HSC) activation and liver fibrosis by stabilizing TUBB4B mRNA in an m6A-dependent fashion. These findings reveal a novel molecular axis with therapeutic potential for targeting fibrotic liver disease.
Arachidonic Acid: Mechanistic Leverage for Translational Imm
2026-08-04
This thought-leadership article explores arachidonic acid’s pivotal role as a polyunsaturated omega-6 fatty acid in immune modulation and translational research. Integrating emerging clinical evidence, mechanistic insights, and protocol guidance, it equips bench-to-bedside teams to harness eicosanoid biosynthesis pathways for rapid, robust humoral immunity.
Genotoxicity Assessment of Glutaraldehyde: Lessons for 6-Thi
2026-08-03
This article analyzes a pivotal study evaluating the genotoxicity of glutaraldehyde through comprehensive in vitro and in vivo assays. The findings clarify assay-specific responses and inform the interpretation of 6-thioguanine resistance endpoints in genetic toxicology, guiding researchers in assay design and cross-study comparison.
iRhom2's Role in Olfactory Receptor Regulation and Adaptatio
2026-08-03
The referenced study uncovers iRhom2 as a unique modulator of olfactory receptor expression and adaptation in olfactory sensory neurons. These findings illuminate the molecular feedback mechanisms underlying sensory plasticity and provide new context for the regulation of GPCR-mediated signaling in the olfactory system.
Vardenafil HCl Trihydrate: Proteoform Precision in Translati
2026-08-02
This thought-leadership article explores how Vardenafil HCl Trihydrate, a potent and selective PDE5 inhibitor, is reshaping translational research at the intersection of proteoform diversity, native membrane signaling, and drug development. Integrating recent advances in native mass spectrometry and proteomics, we provide mechanistic insights, experimental best practices, and strategic guidance for maximizing reproducibility and translational impact, while positioning APExBIO as a trusted partner for high-fidelity smooth muscle and cGMP signaling research.
461 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page